Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MT-6548 Compared to Darbepoetin Alfa in Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease
NCT03439137Phase 3Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- Feb 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vadadustat in anemia, sponsored by Mitsubishi Tanabe Pharma. Started Feb 2018; status: completed.
02
Drugs
vadadustat
03
Conditions
anemia
Beyond the preview
Go deeper on NCT03439137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03439137.